 | • レポートコード：MRC2Q12-18895 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品＆医療 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、ブロモプリドのグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 ブロモプリドのアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ブロモプリドの中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 ブロモプリドのヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までのブロモプリドの生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別のブロモプリドの売上および2028年までの予測に焦点を当てています。 ブロモプリドのグローバル主要企業には、Lebsa、MedChemExpress、ICROM、Cayman、SimSon Pharma、TLC、ALFA Chemistry、Manus Aktteva Biopharma LLP、Cayman Chemical 、Anant Pharmaceuticalsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 ブロモプリド市場は、タイプとアプリケーションによって区分されます。世界のブロモプリド市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 純度98%、純度99%、その他 【アプリケーション別セグメント】 化粧品、医薬品、農業、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - ブロモプリド製品概要 - タイプ別市場（純度98%、純度99%、その他） - アプリケーション別市場（化粧品、医薬品、農業、その他） - 調査の目的 ・エグゼクティブサマリー - 世界のブロモプリド販売量予測2017-2028 - 世界のブロモプリド売上予測2017-2028 - ブロモプリドの地域別販売量 - ブロモプリドの地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別ブロモプリド販売量 - 主要メーカー別ブロモプリド売上 - 主要メーカー別ブロモプリド価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（純度98%、純度99%、その他） - ブロモプリドのタイプ別販売量 - ブロモプリドのタイプ別売上 - ブロモプリドのタイプ別価格 ・アプリケーション別市場規模（化粧品、医薬品、農業、その他） - ブロモプリドのアプリケーション別販売量 - ブロモプリドのアプリケーション別売上 - ブロモプリドのアプリケーション別価格 ・北米市場 - 北米のブロモプリド市場規模（タイプ別、アプリケーション別） - 主要国別のブロモプリド市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパのブロモプリド市場規模（タイプ別、アプリケーション別） - 主要国別のブロモプリド市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋のブロモプリド市場規模（タイプ別、アプリケーション別） - 主要国別のブロモプリド市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米のブロモプリド市場規模（タイプ別、アプリケーション別） - 主要国別のブロモプリド市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカのブロモプリド市場規模（タイプ別、アプリケーション別） - 主要国別のブロモプリド市場規模（トルコ、サウジアラビア） ・企業情報 Lebsa、MedChemExpress、ICROM、Cayman、SimSon Pharma、TLC、ALFA Chemistry、Manus Aktteva Biopharma LLP、Cayman Chemical 、Anant Pharmaceuticals ・産業チェーン及び販売チャネル分析 - ブロモプリドの産業チェーン分析 - ブロモプリドの原材料 - ブロモプリドの生産プロセス - ブロモプリドの販売及びマーケティング - ブロモプリドの主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - ブロモプリドの産業動向 - ブロモプリドのマーケットドライバー - ブロモプリドの課題 - ブロモプリドの阻害要因 ・主な調査結果 |
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Bromopride is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Bromopride is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Bromopride is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Bromopride include Lebsa, MedChemExpress, ICROM, Cayman, SimSon Pharma, TLC, ALFA Chemistry, Manus Aktteva Biopharma LLP and Cayman Chemical , etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Bromopride manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Bromopride market. Further, it explains the major drivers and regional dynamics of the global Bromopride market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Lebsa
MedChemExpress
ICROM
Cayman
SimSon Pharma
TLC
ALFA Chemistry
Manus Aktteva Biopharma LLP
Cayman Chemical
Anant Pharmaceuticals
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Bromopride Segment by Type
98% Pure
99% Pure
Other
Bromopride Segment by Application
Cosmetic
Drug
Agriculture
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Bromopride market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Bromopride, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Bromopride, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Bromopride, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Bromopride sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Bromopride market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Bromopride sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Lebsa, MedChemExpress, ICROM, Cayman, SimSon Pharma, TLC, ALFA Chemistry, Manus Aktteva Biopharma LLP and Cayman Chemical , etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Bromopride in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Bromopride manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Bromopride sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Bromopride Product Introduction
1.2 Market by Type
1.2.1 Global Bromopride Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 98% Pure
1.2.3 99% Pure
1.2.4 Other
1.3 Market by Application
1.3.1 Global Bromopride Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cosmetic
1.3.3 Drug
1.3.4 Agriculture
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bromopride Sales Estimates and Forecasts 2017-2028
2.2 Global Bromopride Revenue Estimates and Forecasts 2017-2028
2.3 Global Bromopride Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Bromopride Sales by Region
2.4.1 Global Bromopride Sales by Region (2017-2022)
2.4.2 Global Sales Bromopride by Region (2023-2028)
2.5 Global Bromopride Revenue by Region
2.5.1 Global Bromopride Revenue by Region (2017-2022)
2.5.2 Global Bromopride Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Bromopride Sales by Manufacturers
3.1.1 Global Top Bromopride Manufacturers by Sales (2017-2022)
3.1.2 Global Bromopride Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bromopride in 2021
3.2 Global Bromopride Revenue by Manufacturers
3.2.1 Global Bromopride Revenue by Manufacturers (2017-2022)
3.2.2 Global Bromopride Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Bromopride Revenue in 2021
3.3 Global Bromopride Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Bromopride Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Bromopride Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Bromopride Sales by Type
4.1.1 Global Bromopride Historical Sales by Type (2017-2022)
4.1.2 Global Bromopride Forecasted Sales by Type (2023-2028)
4.1.3 Global Bromopride Sales Market Share by Type (2017-2028)
4.2 Global Bromopride Revenue by Type
4.2.1 Global Bromopride Historical Revenue by Type (2017-2022)
4.2.2 Global Bromopride Forecasted Revenue by Type (2023-2028)
4.2.3 Global Bromopride Revenue Market Share by Type (2017-2028)
4.3 Global Bromopride Price by Type
4.3.1 Global Bromopride Price by Type (2017-2022)
4.3.2 Global Bromopride Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Bromopride Sales by Application
5.1.1 Global Bromopride Historical Sales by Application (2017-2022)
5.1.2 Global Bromopride Forecasted Sales by Application (2023-2028)
5.1.3 Global Bromopride Sales Market Share by Application (2017-2028)
5.2 Global Bromopride Revenue by Application
5.2.1 Global Bromopride Historical Revenue by Application (2017-2022)
5.2.2 Global Bromopride Forecasted Revenue by Application (2023-2028)
5.2.3 Global Bromopride Revenue Market Share by Application (2017-2028)
5.3 Global Bromopride Price by Application
5.3.1 Global Bromopride Price by Application (2017-2022)
5.3.2 Global Bromopride Price Forecast by Application (2023-2028)
6 North America
6.1 North America Bromopride Market Size by Type
6.1.1 North America Bromopride Sales by Type (2017-2028)
6.1.2 North America Bromopride Revenue by Type (2017-2028)
6.2 North America Bromopride Market Size by Application
6.2.1 North America Bromopride Sales by Application (2017-2028)
6.2.2 North America Bromopride Revenue by Application (2017-2028)
6.3 North America Bromopride Market Size by Country
6.3.1 North America Bromopride Sales by Country (2017-2028)
6.3.2 North America Bromopride Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Bromopride Market Size by Type
7.1.1 Europe Bromopride Sales by Type (2017-2028)
7.1.2 Europe Bromopride Revenue by Type (2017-2028)
7.2 Europe Bromopride Market Size by Application
7.2.1 Europe Bromopride Sales by Application (2017-2028)
7.2.2 Europe Bromopride Revenue by Application (2017-2028)
7.3 Europe Bromopride Market Size by Country
7.3.1 Europe Bromopride Sales by Country (2017-2028)
7.3.2 Europe Bromopride Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Bromopride Market Size by Type
8.1.1 Asia Pacific Bromopride Sales by Type (2017-2028)
8.1.2 Asia Pacific Bromopride Revenue by Type (2017-2028)
8.2 Asia Pacific Bromopride Market Size by Application
8.2.1 Asia Pacific Bromopride Sales by Application (2017-2028)
8.2.2 Asia Pacific Bromopride Revenue by Application (2017-2028)
8.3 Asia Pacific Bromopride Market Size by Region
8.3.1 Asia Pacific Bromopride Sales by Region (2017-2028)
8.3.2 Asia Pacific Bromopride Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Bromopride Market Size by Type
9.1.1 Latin America Bromopride Sales by Type (2017-2028)
9.1.2 Latin America Bromopride Revenue by Type (2017-2028)
9.2 Latin America Bromopride Market Size by Application
9.2.1 Latin America Bromopride Sales by Application (2017-2028)
9.2.2 Latin America Bromopride Revenue by Application (2017-2028)
9.3 Latin America Bromopride Market Size by Country
9.3.1 Latin America Bromopride Sales by Country (2017-2028)
9.3.2 Latin America Bromopride Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Bromopride Market Size by Type
10.1.1 Middle East and Africa Bromopride Sales by Type (2017-2028)
10.1.2 Middle East and Africa Bromopride Revenue by Type (2017-2028)
10.2 Middle East and Africa Bromopride Market Size by Application
10.2.1 Middle East and Africa Bromopride Sales by Application (2017-2028)
10.2.2 Middle East and Africa Bromopride Revenue by Application (2017-2028)
10.3 Middle East and Africa Bromopride Market Size by Country
10.3.1 Middle East and Africa Bromopride Sales by Country (2017-2028)
10.3.2 Middle East and Africa Bromopride Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Lebsa
11.1.1 Lebsa Corporation Information
11.1.2 Lebsa Overview
11.1.3 Lebsa Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Lebsa Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Lebsa Recent Developments
11.2 MedChemExpress
11.2.1 MedChemExpress Corporation Information
11.2.2 MedChemExpress Overview
11.2.3 MedChemExpress Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 MedChemExpress Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 MedChemExpress Recent Developments
11.3 ICROM
11.3.1 ICROM Corporation Information
11.3.2 ICROM Overview
11.3.3 ICROM Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ICROM Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ICROM Recent Developments
11.4 Cayman
11.4.1 Cayman Corporation Information
11.4.2 Cayman Overview
11.4.3 Cayman Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Cayman Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Cayman Recent Developments
11.5 SimSon Pharma
11.5.1 SimSon Pharma Corporation Information
11.5.2 SimSon Pharma Overview
11.5.3 SimSon Pharma Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 SimSon Pharma Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 SimSon Pharma Recent Developments
11.6 TLC
11.6.1 TLC Corporation Information
11.6.2 TLC Overview
11.6.3 TLC Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 TLC Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 TLC Recent Developments
11.7 ALFA Chemistry
11.7.1 ALFA Chemistry Corporation Information
11.7.2 ALFA Chemistry Overview
11.7.3 ALFA Chemistry Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 ALFA Chemistry Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ALFA Chemistry Recent Developments
11.8 Manus Aktteva Biopharma LLP
11.8.1 Manus Aktteva Biopharma LLP Corporation Information
11.8.2 Manus Aktteva Biopharma LLP Overview
11.8.3 Manus Aktteva Biopharma LLP Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Manus Aktteva Biopharma LLP Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Manus Aktteva Biopharma LLP Recent Developments
11.9 Cayman Chemical
11.9.1 Cayman Chemical Corporation Information
11.9.2 Cayman Chemical Overview
11.9.3 Cayman Chemical Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Cayman Chemical Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Cayman Chemical Recent Developments
11.10 Anant Pharmaceuticals
11.10.1 Anant Pharmaceuticals Corporation Information
11.10.2 Anant Pharmaceuticals Overview
11.10.3 Anant Pharmaceuticals Bromopride Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Anant Pharmaceuticals Bromopride Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Anant Pharmaceuticals Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Bromopride Industry Chain Analysis
12.2 Bromopride Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Bromopride Production Mode & Process
12.4 Bromopride Sales and Marketing
12.4.1 Bromopride Sales Channels
12.4.2 Bromopride Distributors
12.5 Bromopride Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Bromopride Industry Trends
13.2 Bromopride Market Drivers
13.3 Bromopride Market Challenges
13.4 Bromopride Market Restraints
14 Key Findings in The Global Bromopride Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer